US20230135830A1 - Needle guidance device for brachytherapy and method of use - Google Patents
Needle guidance device for brachytherapy and method of use Download PDFInfo
- Publication number
- US20230135830A1 US20230135830A1 US17/991,020 US202217991020A US2023135830A1 US 20230135830 A1 US20230135830 A1 US 20230135830A1 US 202217991020 A US202217991020 A US 202217991020A US 2023135830 A1 US2023135830 A1 US 2023135830A1
- Authority
- US
- United States
- Prior art keywords
- needle
- brachytherapy
- tissue
- needle guidance
- guidance device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002725 brachytherapy Methods 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims description 50
- 210000000481 breast Anatomy 0.000 claims abstract description 30
- 238000004873 anchoring Methods 0.000 claims abstract description 16
- 230000002285 radioactive effect Effects 0.000 claims description 29
- 238000003780 insertion Methods 0.000 claims description 11
- 230000037431 insertion Effects 0.000 claims description 11
- 238000003384 imaging method Methods 0.000 claims description 7
- 238000002059 diagnostic imaging Methods 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims 5
- 230000005855 radiation Effects 0.000 description 16
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000002513 implantation Methods 0.000 description 8
- 238000002604 ultrasonography Methods 0.000 description 8
- 239000003550 marker Substances 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 229920000547 conjugated polymer Polymers 0.000 description 1
- 238000011982 device technology Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000004549 pulsed laser deposition Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229910001256 stainless steel alloy Inorganic materials 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
- A61N2005/1009—Apparatus for loading seeds into magazines or needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body
- A61N2005/1012—Templates or grids for guiding the introduction of sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1024—Seeds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1025—Wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1014—Intracavitary radiation therapy
- A61N5/1015—Treatment of resected cavities created by surgery, e.g. lumpectomy
Definitions
- the disclosure relates generally to a mechanism and method for radiation oncology.
- accelerated partial breast irradiation may be used which results in a quicker treatment time and less radiation-induced acute skin reactions.
- One technique used for the accelerated partial breast irradiation is brachytherapy.
- radioactive sources are permanently implanted into the breast tissue at the site of the surgery wherein the radioactive sources may be high dose or low dose.
- a clinician would place hollow catheters into the breast to facilitate the insertion of a temporary radioactive source per a treatment plan which are then removed once the treatment is completed.
- the placement of these catheters may be by either free hand directly into the breast or by free hand though compressive template systems used to stereo-tactically immobilize the breast. Both Varian Medical Systems and Nucletron offer commercially available template immobilization products.
- the fiducial needle can migrate/move once inserted thus changing the depth at which the source strands are deployed.
- the system is very cumbersome to use and is not user intuitive.
- the user manually operates the locking template and stereotactic fixation system by turning knobs to adjust and lock/unlock positions.
- the position and orientation of the locking template is determined by a treatment planning software.
- the correct position and orientation of the template are verified by other instruments such as an inclinometer and a ruler. Overall, the system can be difficult to use in a reproducible and precise manner.
- a needle guidance device that can mark the treatment area with the goal of improving the reproducibility of the procedure and ensuring that the sources are reliably and consistently inserted in an exact position per a patient prescription treatment plan from patient to patient as well as improve the ease-of-use of the device and procedure and it is to this end that the disclosure is directed.
- FIG. 1 is a caudal cross section of breast tissue and an example of the needle guidance device used with a fiducial needle;
- FIG. 2 illustrates a method of using the needle guidance device shown in FIG. 1 ;
- FIG. 3 is a caudal cross section of breast tissue and illustrates another example of the needle guidance device used with a brachytherapy fiducial needle fixation system
- FIG. 4 illustrates another method of using the needle guidance device shown in FIG. 3 .
- the following disclosure is particularly applicable to radioactive source implantation into breast tissue and it is in this context that the disclosure will be described with an example. It will be appreciated, however, that the device and method has greater utility since the device can be used with other devices besides the template, needles, and radioactive sources and in various different tissues in which it would be desirable to be able to perform brachytherapy using radioactive seeds. Furthermore, although the example below illustrates a fiducial needle being guided into breast tissue, the device also may be used to guide other brachytherapy devices into the tissue.
- FIG. 1 is a caudal cross section of breast tissue and an example of the needle guidance device 100 used with a fiducial needle to guide one or more fiducial needles 112 to a treatment region 110 within tissue.
- the tissue is breast tissue 102 shown against a chest wall 104 of a patient that has the treatment region.
- one or more radioactive seeds or strands of seeds may be placed into the tissue (based on a treatment plan) to irradiate a tumor in the tissue or irradiate a margin from which a tumor has been removed by the radiation released by the one or more radioactive seeds.
- the needle guidance device 100 may be used to guide a needle into various different tissues and is not in any way limited to the example use in breast tissue shown in FIG. 1 .
- a needle guidance device 106 may be inserted into and secured in the tissue.
- the needle guidance device may have a body portion that can attach onto or take in a needle, such as the exemplary fiducial needle 112 shown in FIG. 1 .
- Example of the needle guidance device 106 and its body portion may include, for example, a hollow tube, such as a catheter or cannula, through which a needle can be inserted (as shown in the example in FIG. 1 ), a guidewire that can be used with a hollow needle, a balloon catheter, through which a needle can be inserted and/or a balloon on a guidewire.
- the needle guidance device 106 may have an anchoring feature 108 that secures the device 106 into the tissue, but is easily removable.
- Examples of the anchoring feature 108 may include, for example, holes for suturing the device 106 into the tissue as shown in the example in FIG. 1 , one or more hooks can be deployed into the tissue as in the example embodiment shown in FIG. 3 , a screw-like tip (tip has threads) can be used to secure the device 106 into tissue and/or a balloon can be inflated inside the cavity to secure the device 106 .
- the device 106 may be manufactured out of a polymer-based material, stainless steel, stainless steel alloys, bioabsorbable materials or any other suitable material.
- the device 106 may have a feature 114 that allows the device 106 to be placed percutaneously into the cavity (for example, formed when a tumor has been surgically removed) in the treatment region 110 .
- the feature 114 may be, for example, a sharpened tip (such as shown in the examples in FIGS. 1 and 3 ) to facilitate easy penetration into tissue or an accessory component such as a trochar can be used to place the device 106 into the tissue.
- the device 106 or at least one portion of the device 106 may be visible under one or more imaging modalities (e.g., fluoroscopy, magnetic resonance imaging, computerized tomography, ultrasound, etc.).
- imaging modalities e.g., fluoroscopy, magnetic resonance imaging, computerized tomography, ultrasound, etc.
- the entire body of the device 106 may be visible, features on or inside the device (i.e., beads, bands, markers, imaging agent) may be visible, balloon can be inflated for visibility and/or an accessory component that is visible under medical imaging can be placed inside the device wherein the accessory component may have features for depth measurements.
- the device 106 may also have an interface feature 116 at an end of the body portion at each end of the body portion that includes the anchoring feature so that the device 106 can accept and interface with one or more brachytherapy devices, including a needle.
- an end of the device 106 may have a flared opening to ease the insertion of a fiducial device, such as a needle and/or may have a cap can be attached to the end of the device, on the skin surface, with an accessible opening for a fiducial device, such as a needle, to enter the device as shown in the example in FIG. 1 .
- the device 106 may contain electronic components, such as sensors, that can communicate or interact with software.
- the location of the device 106 can be identified with software and the treatment plan can be adjusted according to the location of the device 106 .
- the device 106 can be used with an ultrasound imaging system to provide real-time location of the insertion and guidance at the time the device is implanted which provides visualization of the surrounding tissue on a screen.
- the interface feature 116 anchors the needle guidance device 106 on each end of the treatment site, although the needle guidance device 106 may also be anchored only on one side of the treatment site.
- the interface feature 116 also may be, for example, a button, sutures, both button and suture, or some other type of anchoring feature.
- FIG. 2 illustrates a method 200 of using the needle guidance device shown in FIG. 1 .
- the needle guidance device is used to place one or more brachytherapy seeds into a treatment region which is a lumpectomy cavity in breast tissue from which a tumor was surgically removed previously.
- a brachytherapy procedure in which one or more radioactive seeds are placed into the treatment region, one or more fiducial needles are first fixated into the treatment region through a brachytherapy template and then needles with the one or more radioactive seeds are inserted through the template (fixated by at least one fiducial needle) to place the one or more radioactive seeds precisely into the treatment region based on a treatment plan.
- the installed one or more radioactive seeds release radiation that irradiates the tissue in the treatment region.
- the one or more radioactive seeds kill tumor cells in the lumpectomy region that remain after surgery to remove a tumor.
- the needle guidance device 106 in the form of a cannula in one embodiment, is placed at the time of lumpectomy in the treatment region that is the lumpectomy cavity ( 202 ).
- the needle guidance device 106 may be secured in the lumpectomy cavity with sutures ( 204 ) to prevent migration.
- a CT-visible marker is placed inside the device for treatment planning.
- the CT-visible marker has bands spaced 1 cm apart for depth measurements.
- Treatment planning (using treatment planning software) is done using the device as a reference point ( 206 ).
- the need guidance device is imaged and the treatment planning software ( 207 ) is used to plan one or more characteristics of the insertion of a brachytherapy needle, such as placement, angle and/or depth of insertion) prior to the procedure.
- the CT-visible marker is removed after the plan.
- a template grid of the brachytherapy fiducial needle fixation system (an example of which is described in U.S. Pat. No. 8,764,619 that is incorporated herein by reference) is set up.
- a fiducial needle may then be placed through the grid and inside the needle guidance device 106 ( 208 ) without the need for ultrasound guidance since the implanted needle guidance device 106 precisely guides the needles.
- the radioactive seeds may then be implanted per the treatment plan ( 210 ). Ultrasound guidance can be used for verification of the final placement of the radioactive seeds.
- the needle guidance device 106 , the fiducial needles and other components then may be removed after the completion of the procedure ( 212 ).
- the needle guidance device 106 may be placed percutaneously with a trochar.
- the device is visible under CT and ultrasound imaging.
- the needle guidance device 106 may be secured in the lumpectomy cavity with an inflated balloon. Treatment planning is done using the device as a reference point.
- the fiducial needle uses the guidewire component of the device as a track into the cavity without ultrasound guidance. Ultrasound guidance can be used for verification of the final placement. The device is removed after the completion of the procedure.
- FIG. 3 is a caudal cross section of breast tissue and illustrates another example of the needle guidance device 106 used with a brachytherapy fiducial needle fixation system.
- the needle guidance device 106 may have one or more deployable hooks 302 that may be the anchor device used to anchor the installed needle guidance device 106 at the treatment region 110 .
- the hook(s) may be withdrawn into a distal end of the needle guidance device 106 during installation and then be deployed as shown in FIG. 3 once the needle guidance device 106 is placed adjacent/in the treatment region 110 .
- Each hook may be spring biased so that it deploys once released.
- the hooks 302 may also use the same spring mechanism or a different spring mechanism to retreat the hooks for removal of the device.
- the needle guidance device 106 may also have a brachytherapy needle template guide 304 that is attached to the needle guidance device 106 as shown.
- the needle template guide 304 is a template through which fiducial needles and/or radioactive seed/source needles are guided into the treatment site in order to place one or more radioactive seeds/sources into/adjacent the treatment site.
- FIG. 4 illustrates another method 400 of using the needle guidance device shown in FIG. 3 .
- the needle guidance device is used to place one or more brachytherapy seeds into a treatment region which is a lumpectomy cavity in breast tissue from which a tumor was surgically removed previously.
- the needle guidance device 106 in the form of a cannula in one embodiment, is placed at the time of lumpectomy in the treatment region that is the lumpectomy cavity ( 402 ).
- the needle guidance device 106 may be secured in the lumpectomy cavity using the deployed hooks ( 404 ) to prevent migration.
- a CT-visible marker is placed inside the device for treatment planning.
- the CT-visible marker has bands spaced 1 cm apart for depth measurements.
- Treatment planning (with known treatment planning software) is done using the device as a reference point ( 406 ).
- the need guidance device is imaged and the treatment planning software ( 407 ) is used to plan one or more characteristics of the insertion of a brachytherapy needle, such as placement, angle and/or depth of insertion) prior to the procedure.
- the CT-visible marker may be removed after the plan.
- a template grid of the brachytherapy fiducial needle fixation system (an example of which is described in U.S. Pat. No. 8,764,619 that is incorporated herein by reference) is set up and placed into position ( 408 ). Then, a fiducial needle may be placed through the grid and inside the needle guidance device 106 ( 410 ) and secured without the need for ultrasound guidance since the implanted needle guidance device 106 precisely guides the needles. The radioactive seeds may then be implanted per the treatment plan ( 412 ). Ultrasound guidance can be used for verification of the final placement of the radioactive seeds. The needle guidance device 106 , the fiducial needles and other components then may be removed after the completion of the procedure ( 412 ).
- the needle guidance device 106 may be a catheter that is open at both ends (unlike the embodiment shown in FIG. 1 ) that is inserted inside the body with a trocar which is the element that penetrates the tissue. Once the device 106 is inserted percutaneously inside the body, the trocar is removed. The device 106 may be anchored in place with a button at the skin surface. A brachytherapy needle is inserted inside the device for the placement of one or more radioactive seeds inside the body. The brachytherapy needle is removed and a fiducial needle is inserted inside so that it can be fixated with a brachytherapy needle template grid. The other brachytherapy needles can be inserted with the brachytherapy needle template grid.
- system and method disclosed herein may be implemented via one or more components, systems, servers, appliances, other subcomponents, or distributed between such elements.
- systems may include an/or involve, inter alia, components such as software modules, general-purpose CPU, RAM, etc. found in general-purpose computers.
- components such as software modules, general-purpose CPU, RAM, etc. found in general-purpose computers.
- a server may include or involve components such as CPU, RAM, etc., such as those found in general-purpose computers.
- system and method herein may be achieved via implementations with disparate or entirely different software, hardware and/or firmware components, beyond that set forth above.
- components e.g., software, processing components, etc.
- computer-readable media associated with or embodying the present inventions
- aspects of the innovations herein may be implemented consistent with numerous general purpose or special purpose computing systems or configurations.
- exemplary computing systems, environments, and/or configurations may include, but are not limited to: software or other components within or embodied on personal computers, servers or server computing devices such as routing/connectivity components, hand-held or laptop devices, multiprocessor systems, microprocessor-based systems, set top boxes, consumer electronic devices, network PCs, other existing computer platforms, distributed computing environments that include one or more of the above systems or devices, etc.
- aspects of the system and method may be achieved via or performed by logic and/or logic instructions including program modules, executed in association with such components or circuitry, for example.
- program modules may include routines, programs, objects, components, data structures, etc. that perform particular tasks or implement particular instructions herein.
- the inventions may also be practiced in the context of distributed software, computer, or circuit settings where circuitry is connected via communication buses, circuitry or links. In distributed settings, control/instructions may occur from both local and remote computer storage media including memory storage devices.
- Computer readable media can be any available media that is resident on, associable with, or can be accessed by such circuits and/or computing components.
- Computer readable media may comprise computer storage media and communication media.
- Computer storage media includes volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data.
- Computer storage media includes, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and can accessed by computing component.
- Communication media may comprise computer readable instructions, data structures, program modules and/or other components. Further, communication media may include wired media such as a wired network or direct-wired connection, however no media of any such type herein includes transitory media. Combinations of the any of the above are also included within the scope of computer readable media.
- the terms component, module, device, etc. may refer to any type of logical or functional software elements, circuits, blocks and/or processes that may be implemented in a variety of ways.
- the functions of various circuits and/or blocks can be combined with one another into any other number of modules.
- Each module may even be implemented as a software program stored on a tangible memory (e.g., random access memory, read only memory, CD-ROM memory, hard disk drive, etc.) to be read by a central processing unit to implement the functions of the innovations herein.
- the modules can comprise programming instructions transmitted to a general purpose computer or to processing/graphics hardware via a transmission carrier wave.
- the modules can be implemented as hardware logic circuitry implementing the functions encompassed by the innovations herein.
- the modules can be implemented using special purpose instructions (SIMD instructions), field programmable logic arrays or any mix thereof which provides the desired level performance and cost.
- SIMD instructions special purpose instructions
- features consistent with the disclosure may be implemented via computer-hardware, software and/or firmware.
- the systems and methods disclosed herein may be embodied in various forms including, for example, a data processor, such as a computer that also includes a database, digital electronic circuitry, firmware, software, or in combinations of them.
- a data processor such as a computer that also includes a database
- digital electronic circuitry such as a computer
- firmware such as a firmware
- software such as a computer
- the systems and methods disclosed herein may be implemented with any combination of hardware, software and/or firmware.
- the above-noted features and other aspects and principles of the innovations herein may be implemented in various environments.
- Such environments and related applications may be specially constructed for performing the various routines, processes and/or operations according to the invention or they may include a general-purpose computer or computing platform selectively activated or reconfigured by code to provide the necessary functionality.
- the processes disclosed herein are not inherently related to any particular computer, network, architecture, environment, or other apparatus, and may be implemented by a suitable combination of hardware, software, and/or firmware.
- various general-purpose machines may be used with programs written in accordance with teachings of the invention, or it may be more convenient to construct a specialized apparatus or system to perform the required methods and techniques.
- aspects of the method and system described herein, such as the logic may also be implemented as functionality programmed into any of a variety of circuitry, including programmable logic devices (“PLDs”), such as field programmable gate arrays (“FPGAs”), programmable array logic (“PAL”) devices, electrically programmable logic and memory devices and standard cell-based devices, as well as application specific integrated circuits.
- PLDs programmable logic devices
- FPGAs field programmable gate arrays
- PAL programmable array logic
- Some other possibilities for implementing aspects include: memory devices, microcontrollers with memory (such as EEPROM), embedded microprocessors, firmware, software, etc.
- aspects may be embodied in microprocessors having software-based circuit emulation, discrete logic (sequential and combinatorial), custom devices, fuzzy (neural) logic, quantum devices, and hybrids of any of the above device types.
- the underlying device technologies may be provided in a variety of component types, e.g., metal-oxide semiconductor field-effect transistor (“MOSFET”) technologies like complementary metal-oxide semiconductor (“CMOS”), bipolar technologies like emitter-coupled logic (“ECL”), polymer technologies (e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures), mixed analog and digital, and so on.
- MOSFET metal-oxide semiconductor field-effect transistor
- CMOS complementary metal-oxide semiconductor
- ECL emitter-coupled logic
- polymer technologies e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures
- mixed analog and digital and so on.
- the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number respectively. Additionally, the words “herein,” “hereunder,” “above,” “below,” and words of similar import refer to this application as a whole and not to any particular portions of this application. When the word “or” is used in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list and any combination of the items in the list.
Abstract
A brachytherapy needle guidance device is a device that facilitates the placement of a brachytherapy needle into a treatment region in tissue. This tissue may a breast tissue and the brachytherapy needle may be a fiducial needle. The brachytherapy needle guidance device may have an anchoring feature that anchors the brachytherapy needle guidance device into the tissue once it is properly positioned. The brachytherapy needle guidance device is used by software for treatment planning.
Description
- This application is a continuation and claims priority under 35 USC 120, 121 to U.S. patent application Ser. No. 16/801,103, filed Feb. 25, 2020 that claims the benefit under 35 USC 119(e) of U.S. Provisional Application No. 62/812,197, filed Feb. 28, 2019, both of which are incorporated herein by reference.
- The disclosure relates generally to a mechanism and method for radiation oncology.
- When women are treated for breast cancer (which is the most commonly diagnosed cancer in women), they can opt for a mastectomy (complete removal of the breast tissue) or a breast conservation surgery. Due to the use of widespread screening mammograms, women are diagnosed with localized and early-stage disease so that the breast conservation surgery followed by radiation treatment may be used. The typical radiation treatment is adjuvant breast radiation. While the adjuvant breast radiation results in good survival rates, adjuvant breast radiation treatment typically takes 3.5 to 7 weeks which is too long. In addition, since the adjuvant breast radiation treatment is typically provided using external beam radiation, there is a greater risk of acute skin reactions due to the healthy tissue interaction with the radiation.
- As a result, accelerated partial breast irradiation may be used which results in a quicker treatment time and less radiation-induced acute skin reactions. One technique used for the accelerated partial breast irradiation is brachytherapy. In one method, radioactive sources are permanently implanted into the breast tissue at the site of the surgery wherein the radioactive sources may be high dose or low dose.
- Currently there are a handful of ways to insert radioactive sources into breast tissue. One is by a free hand method, another uses a compressive template device to temporary hold insertion catheters and the last uses a locking template system and non-fixated fiducial needle. These methods are limited in that they do not ensure the sources are placed in the desired location as prescribed by the
treatment plan 100% of the time. The lack of ability to place the radioactive sources in the desired location means that the remaining tumor margin is not receiving the appropriate radiation and healthy tissue is receiving unwanted radiation. - In the high dose rate brachytherapy area, a clinician would place hollow catheters into the breast to facilitate the insertion of a temporary radioactive source per a treatment plan which are then removed once the treatment is completed. The placement of these catheters may be by either free hand directly into the breast or by free hand though compressive template systems used to stereo-tactically immobilize the breast. Both Varian Medical Systems and Nucletron offer commercially available template immobilization products.
- In the low dose rate brachytherapy area, one method for permanent breast radioactive seed implantation is described in detail in “First Report of a Permanent Breast103PD Seed Implant As Adjuvant Radiation Treatment for Early-Stage Breast Cancer”, Dr. Jean-Philippe Pignol et al., International Journal of Radiation Oncology Biological Physics, Vol. 64, No. 1, pp. 176-181 (2006) which is incorporated herein by reference. This method uses a non-fixated fiducial needle, locking template and stereotactic fixation to insert lose dose rate (LDR) radioactive source strands into the treatment site. In this method, the fiducial needle can be challenging to place in the surgical cavity because locating the surgical cavity relies on the user's ultrasound skills. Also, the fiducial needle can migrate/move once inserted thus changing the depth at which the source strands are deployed. In addition, the system is very cumbersome to use and is not user intuitive. The user manually operates the locking template and stereotactic fixation system by turning knobs to adjust and lock/unlock positions. The position and orientation of the locking template is determined by a treatment planning software. The correct position and orientation of the template are verified by other instruments such as an inclinometer and a ruler. Overall, the system can be difficult to use in a reproducible and precise manner.
- Thus, it is desirable to provide a needle guidance device that can mark the treatment area with the goal of improving the reproducibility of the procedure and ensuring that the sources are reliably and consistently inserted in an exact position per a patient prescription treatment plan from patient to patient as well as improve the ease-of-use of the device and procedure and it is to this end that the disclosure is directed.
-
FIG. 1 is a caudal cross section of breast tissue and an example of the needle guidance device used with a fiducial needle; -
FIG. 2 illustrates a method of using the needle guidance device shown inFIG. 1 ; -
FIG. 3 is a caudal cross section of breast tissue and illustrates another example of the needle guidance device used with a brachytherapy fiducial needle fixation system; and -
FIG. 4 illustrates another method of using the needle guidance device shown inFIG. 3 . - It is noted that the following disclosure is particularly applicable to radioactive source implantation into breast tissue and it is in this context that the disclosure will be described with an example. It will be appreciated, however, that the device and method has greater utility since the device can be used with other devices besides the template, needles, and radioactive sources and in various different tissues in which it would be desirable to be able to perform brachytherapy using radioactive seeds. Furthermore, although the example below illustrates a fiducial needle being guided into breast tissue, the device also may be used to guide other brachytherapy devices into the tissue.
-
FIG. 1 is a caudal cross section of breast tissue and an example of theneedle guidance device 100 used with a fiducial needle to guide one or morefiducial needles 112 to atreatment region 110 within tissue. In the example shown inFIG. 1 , the tissue isbreast tissue 102 shown against achest wall 104 of a patient that has the treatment region. Once the one or more fiducial needles are fixed into a region oftreatment 110, one or more radioactive seeds or strands of seeds may be placed into the tissue (based on a treatment plan) to irradiate a tumor in the tissue or irradiate a margin from which a tumor has been removed by the radiation released by the one or more radioactive seeds. As noted above, theneedle guidance device 100 may be used to guide a needle into various different tissues and is not in any way limited to the example use in breast tissue shown inFIG. 1 . - A
needle guidance device 106 may be inserted into and secured in the tissue. The needle guidance device may have a body portion that can attach onto or take in a needle, such as the exemplaryfiducial needle 112 shown inFIG. 1 . Example of theneedle guidance device 106 and its body portion may include, for example, a hollow tube, such as a catheter or cannula, through which a needle can be inserted (as shown in the example inFIG. 1 ), a guidewire that can be used with a hollow needle, a balloon catheter, through which a needle can be inserted and/or a balloon on a guidewire. Theneedle guidance device 106 may have ananchoring feature 108 that secures thedevice 106 into the tissue, but is easily removable. Examples of theanchoring feature 108 may include, for example, holes for suturing thedevice 106 into the tissue as shown in the example inFIG. 1 , one or more hooks can be deployed into the tissue as in the example embodiment shown inFIG. 3 , a screw-like tip (tip has threads) can be used to secure thedevice 106 into tissue and/or a balloon can be inflated inside the cavity to secure thedevice 106. - The
device 106 may be manufactured out of a polymer-based material, stainless steel, stainless steel alloys, bioabsorbable materials or any other suitable material. Thedevice 106 may have afeature 114 that allows thedevice 106 to be placed percutaneously into the cavity (for example, formed when a tumor has been surgically removed) in thetreatment region 110. Thefeature 114 may be, for example, a sharpened tip (such as shown in the examples inFIGS. 1 and 3 ) to facilitate easy penetration into tissue or an accessory component such as a trochar can be used to place thedevice 106 into the tissue. Thedevice 106 or at least one portion of thedevice 106 may be visible under one or more imaging modalities (e.g., fluoroscopy, magnetic resonance imaging, computerized tomography, ultrasound, etc.). For example, the entire body of thedevice 106 may be visible, features on or inside the device (i.e., beads, bands, markers, imaging agent) may be visible, balloon can be inflated for visibility and/or an accessory component that is visible under medical imaging can be placed inside the device wherein the accessory component may have features for depth measurements. - The
device 106 may also have aninterface feature 116 at an end of the body portion at each end of the body portion that includes the anchoring feature so that thedevice 106 can accept and interface with one or more brachytherapy devices, including a needle. For example, an end of thedevice 106 may have a flared opening to ease the insertion of a fiducial device, such as a needle and/or may have a cap can be attached to the end of the device, on the skin surface, with an accessible opening for a fiducial device, such as a needle, to enter the device as shown in the example inFIG. 1 . Thedevice 106 may contain electronic components, such as sensors, that can communicate or interact with software. For example, the location of thedevice 106 can be identified with software and the treatment plan can be adjusted according to the location of thedevice 106. In addition, thedevice 106 can be used with an ultrasound imaging system to provide real-time location of the insertion and guidance at the time the device is implanted which provides visualization of the surrounding tissue on a screen. In the example inFIG. 1 , the interface feature 116 anchors theneedle guidance device 106 on each end of the treatment site, although theneedle guidance device 106 may also be anchored only on one side of the treatment site. In addition to the alternatives set forth above for the anchoring feature, theinterface feature 116 also may be, for example, a button, sutures, both button and suture, or some other type of anchoring feature. -
FIG. 2 illustrates amethod 200 of using the needle guidance device shown inFIG. 1 . In one example, the needle guidance device is used to place one or more brachytherapy seeds into a treatment region which is a lumpectomy cavity in breast tissue from which a tumor was surgically removed previously. In a brachytherapy procedure in which one or more radioactive seeds are placed into the treatment region, one or more fiducial needles are first fixated into the treatment region through a brachytherapy template and then needles with the one or more radioactive seeds are inserted through the template (fixated by at least one fiducial needle) to place the one or more radioactive seeds precisely into the treatment region based on a treatment plan. The installed one or more radioactive seeds release radiation that irradiates the tissue in the treatment region. In one embodiment, the one or more radioactive seeds kill tumor cells in the lumpectomy region that remain after surgery to remove a tumor. - In the method, the
needle guidance device 106, in the form of a cannula in one embodiment, is placed at the time of lumpectomy in the treatment region that is the lumpectomy cavity (202). Theneedle guidance device 106 may be secured in the lumpectomy cavity with sutures (204) to prevent migration. When the patient is confirmed to receive permanent breast seed implantation, a CT-visible marker is placed inside the device for treatment planning. The CT-visible marker has bands spaced 1 cm apart for depth measurements. Treatment planning (using treatment planning software) is done using the device as a reference point (206). During the treatment planning, the need guidance device is imaged and the treatment planning software (207) is used to plan one or more characteristics of the insertion of a brachytherapy needle, such as placement, angle and/or depth of insertion) prior to the procedure. The CT-visible marker is removed after the plan. - On the day of the radioactive seed implantation (that may be the same day/same time as the treatment planning or at a different time), a template grid of the brachytherapy fiducial needle fixation system (an example of which is described in U.S. Pat. No. 8,764,619 that is incorporated herein by reference) is set up. A fiducial needle may then be placed through the grid and inside the needle guidance device 106 (208) without the need for ultrasound guidance since the implanted
needle guidance device 106 precisely guides the needles. The radioactive seeds may then be implanted per the treatment plan (210). Ultrasound guidance can be used for verification of the final placement of the radioactive seeds. Theneedle guidance device 106, the fiducial needles and other components then may be removed after the completion of the procedure (212). - In an alternative method, when the patient is confirmed to receive permanent breast seed implantation, the
needle guidance device 106 may be placed percutaneously with a trochar. The device is visible under CT and ultrasound imaging. In this embodiment, theneedle guidance device 106 may be secured in the lumpectomy cavity with an inflated balloon. Treatment planning is done using the device as a reference point. On the day of the implantation, the fiducial needle uses the guidewire component of the device as a track into the cavity without ultrasound guidance. Ultrasound guidance can be used for verification of the final placement. The device is removed after the completion of the procedure. -
FIG. 3 is a caudal cross section of breast tissue and illustrates another example of theneedle guidance device 106 used with a brachytherapy fiducial needle fixation system. In this embodiment, many of the elements inFIG. 1 are the same and are labeled as such and will not be further described for this embodiment. In this embodiment, theneedle guidance device 106 may have one or moredeployable hooks 302 that may be the anchor device used to anchor the installedneedle guidance device 106 at thetreatment region 110. In operation, the hook(s) may be withdrawn into a distal end of theneedle guidance device 106 during installation and then be deployed as shown inFIG. 3 once theneedle guidance device 106 is placed adjacent/in thetreatment region 110. Each hook may be spring biased so that it deploys once released. Thehooks 302 may also use the same spring mechanism or a different spring mechanism to retreat the hooks for removal of the device. Theneedle guidance device 106 may also have a brachytherapyneedle template guide 304 that is attached to theneedle guidance device 106 as shown. Theneedle template guide 304 is a template through which fiducial needles and/or radioactive seed/source needles are guided into the treatment site in order to place one or more radioactive seeds/sources into/adjacent the treatment site. -
FIG. 4 illustrates anothermethod 400 of using the needle guidance device shown inFIG. 3 . In one example, the needle guidance device is used to place one or more brachytherapy seeds into a treatment region which is a lumpectomy cavity in breast tissue from which a tumor was surgically removed previously. In the method, theneedle guidance device 106, in the form of a cannula in one embodiment, is placed at the time of lumpectomy in the treatment region that is the lumpectomy cavity (402). Theneedle guidance device 106 may be secured in the lumpectomy cavity using the deployed hooks (404) to prevent migration. When the patient is confirmed to receive permanent breast seed implantation, a CT-visible marker is placed inside the device for treatment planning. The CT-visible marker has bands spaced 1 cm apart for depth measurements. Treatment planning (with known treatment planning software) is done using the device as a reference point (406). During the treatment planning, the need guidance device is imaged and the treatment planning software (407) is used to plan one or more characteristics of the insertion of a brachytherapy needle, such as placement, angle and/or depth of insertion) prior to the procedure. The CT-visible marker may be removed after the plan. - On the day of the radioactive seed implantation (that may be the same day/same time as the treatment planning or at a different time), a template grid of the brachytherapy fiducial needle fixation system (an example of which is described in U.S. Pat. No. 8,764,619 that is incorporated herein by reference) is set up and placed into position (408). Then, a fiducial needle may be placed through the grid and inside the needle guidance device 106 (410) and secured without the need for ultrasound guidance since the implanted
needle guidance device 106 precisely guides the needles. The radioactive seeds may then be implanted per the treatment plan (412). Ultrasound guidance can be used for verification of the final placement of the radioactive seeds. Theneedle guidance device 106, the fiducial needles and other components then may be removed after the completion of the procedure (412). - In an alternative embodiment, the
needle guidance device 106 may be a catheter that is open at both ends (unlike the embodiment shown inFIG. 1 ) that is inserted inside the body with a trocar which is the element that penetrates the tissue. Once thedevice 106 is inserted percutaneously inside the body, the trocar is removed. Thedevice 106 may be anchored in place with a button at the skin surface. A brachytherapy needle is inserted inside the device for the placement of one or more radioactive seeds inside the body. The brachytherapy needle is removed and a fiducial needle is inserted inside so that it can be fixated with a brachytherapy needle template grid. The other brachytherapy needles can be inserted with the brachytherapy needle template grid. - The foregoing description, for purpose of explanation, has been described with reference to specific embodiments. However, the illustrative discussions above are not intended to be exhaustive or to limit the disclosure to the precise forms disclosed. Many modifications and variations are possible in view of the above teachings. The embodiments were chosen and described in order to best explain the principles of the disclosure and its practical applications, to thereby enable others skilled in the art to best utilize the disclosure and various embodiments with various modifications as are suited to the particular use contemplated.
- The system and method disclosed herein may be implemented via one or more components, systems, servers, appliances, other subcomponents, or distributed between such elements. When implemented as a system, such systems may include an/or involve, inter alia, components such as software modules, general-purpose CPU, RAM, etc. found in general-purpose computers. In implementations where the innovations reside on a server, such a server may include or involve components such as CPU, RAM, etc., such as those found in general-purpose computers.
- Additionally, the system and method herein may be achieved via implementations with disparate or entirely different software, hardware and/or firmware components, beyond that set forth above. With regard to such other components (e.g., software, processing components, etc.) and/or computer-readable media associated with or embodying the present inventions, for example, aspects of the innovations herein may be implemented consistent with numerous general purpose or special purpose computing systems or configurations. Various exemplary computing systems, environments, and/or configurations that may be suitable for use with the innovations herein may include, but are not limited to: software or other components within or embodied on personal computers, servers or server computing devices such as routing/connectivity components, hand-held or laptop devices, multiprocessor systems, microprocessor-based systems, set top boxes, consumer electronic devices, network PCs, other existing computer platforms, distributed computing environments that include one or more of the above systems or devices, etc.
- In some instances, aspects of the system and method may be achieved via or performed by logic and/or logic instructions including program modules, executed in association with such components or circuitry, for example. In general, program modules may include routines, programs, objects, components, data structures, etc. that perform particular tasks or implement particular instructions herein. The inventions may also be practiced in the context of distributed software, computer, or circuit settings where circuitry is connected via communication buses, circuitry or links. In distributed settings, control/instructions may occur from both local and remote computer storage media including memory storage devices.
- The software, circuitry and components herein may also include and/or utilize one or more type of computer readable media. Computer readable media can be any available media that is resident on, associable with, or can be accessed by such circuits and/or computing components. By way of example, and not limitation, computer readable media may comprise computer storage media and communication media. Computer storage media includes volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. Computer storage media includes, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information and can accessed by computing component. Communication media may comprise computer readable instructions, data structures, program modules and/or other components. Further, communication media may include wired media such as a wired network or direct-wired connection, however no media of any such type herein includes transitory media. Combinations of the any of the above are also included within the scope of computer readable media.
- In the present description, the terms component, module, device, etc. may refer to any type of logical or functional software elements, circuits, blocks and/or processes that may be implemented in a variety of ways. For example, the functions of various circuits and/or blocks can be combined with one another into any other number of modules. Each module may even be implemented as a software program stored on a tangible memory (e.g., random access memory, read only memory, CD-ROM memory, hard disk drive, etc.) to be read by a central processing unit to implement the functions of the innovations herein. Or, the modules can comprise programming instructions transmitted to a general purpose computer or to processing/graphics hardware via a transmission carrier wave. Also, the modules can be implemented as hardware logic circuitry implementing the functions encompassed by the innovations herein. Finally, the modules can be implemented using special purpose instructions (SIMD instructions), field programmable logic arrays or any mix thereof which provides the desired level performance and cost.
- As disclosed herein, features consistent with the disclosure may be implemented via computer-hardware, software and/or firmware. For example, the systems and methods disclosed herein may be embodied in various forms including, for example, a data processor, such as a computer that also includes a database, digital electronic circuitry, firmware, software, or in combinations of them. Further, while some of the disclosed implementations describe specific hardware components, systems and methods consistent with the innovations herein may be implemented with any combination of hardware, software and/or firmware. Moreover, the above-noted features and other aspects and principles of the innovations herein may be implemented in various environments. Such environments and related applications may be specially constructed for performing the various routines, processes and/or operations according to the invention or they may include a general-purpose computer or computing platform selectively activated or reconfigured by code to provide the necessary functionality. The processes disclosed herein are not inherently related to any particular computer, network, architecture, environment, or other apparatus, and may be implemented by a suitable combination of hardware, software, and/or firmware. For example, various general-purpose machines may be used with programs written in accordance with teachings of the invention, or it may be more convenient to construct a specialized apparatus or system to perform the required methods and techniques.
- Aspects of the method and system described herein, such as the logic, may also be implemented as functionality programmed into any of a variety of circuitry, including programmable logic devices (“PLDs”), such as field programmable gate arrays (“FPGAs”), programmable array logic (“PAL”) devices, electrically programmable logic and memory devices and standard cell-based devices, as well as application specific integrated circuits. Some other possibilities for implementing aspects include: memory devices, microcontrollers with memory (such as EEPROM), embedded microprocessors, firmware, software, etc. Furthermore, aspects may be embodied in microprocessors having software-based circuit emulation, discrete logic (sequential and combinatorial), custom devices, fuzzy (neural) logic, quantum devices, and hybrids of any of the above device types. The underlying device technologies may be provided in a variety of component types, e.g., metal-oxide semiconductor field-effect transistor (“MOSFET”) technologies like complementary metal-oxide semiconductor (“CMOS”), bipolar technologies like emitter-coupled logic (“ECL”), polymer technologies (e.g., silicon-conjugated polymer and metal-conjugated polymer-metal structures), mixed analog and digital, and so on.
- It should also be noted that the various logic and/or functions disclosed herein may be enabled using any number of combinations of hardware, firmware, and/or as data and/or instructions embodied in various machine-readable or computer-readable media, in terms of their behavioral, register transfer, logic component, and/or other characteristics. Computer-readable media in which such formatted data and/or instructions may be embodied include, but are not limited to, non-volatile storage media in various forms (e.g., optical, magnetic or semiconductor storage media) though again does not include transitory media. Unless the context clearly requires otherwise, throughout the description, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number respectively. Additionally, the words “herein,” “hereunder,” “above,” “below,” and words of similar import refer to this application as a whole and not to any particular portions of this application. When the word “or” is used in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list and any combination of the items in the list.
- Although certain presently preferred implementations of the invention have been specifically described herein, it will be apparent to those skilled in the art to which the invention pertains that variations and modifications of the various implementations shown and described herein may be made without departing from the spirit and scope of the invention. Accordingly, it is intended that the invention be limited only to the extent required by the applicable rules of law.
- While the foregoing has been with reference to a particular embodiment of the disclosure, it will be appreciated by those skilled in the art that changes in this embodiment may be made without departing from the principles and spirit of the disclosure, the scope of which is defined by the appended claims
Claims (17)
1. A brachytherapy needle guidance device, comprising:
a hollow body portion having a distal end and a proximal end;
an anchoring feature that is capable of anchoring the hollow body portion into tissue;
an imaging feature that is capable of being imaged by a medical imaging modality and used by a treatment planning software to determine a position and orientation of the hollow body portion;
a feature at the distal end of the hollow body portion that is capable of penetrating the tissue in order to insert the hollow body portion into the tissue; and
wherein a brachytherapy needle is guided into the tissue once the hollow body portion is anchored in the tissue.
2. The device of claim 1 , wherein the anchoring feature is one of a set of holes for suturing, a set of hooks, a button, and an inflatable balloon.
3. The device of claim 1 , wherein the feature that is capable of penetrating the tissue further comprises one of a sharpened tip at a distal end of the hollow body portion and a trocar with an open end.
4. The device of claim 1 , wherein the hollow body portion further comprises one of a guidewire that can be used with a hollow needle and a balloon catheter.
5. The device of claim 1 further comprising a brachytherapy template attached to a proximal end of the hollow body portion.
6. The device of claim 3 , wherein the hollow body portion is a catheter that is inserted into the tissue using the trocar.
7. A method for guiding a brachytherapy needle, the method comprising:
providing a needle guidance device having a hollow body portion having a distal end and a proximal end, an anchoring feature that is capable of anchoring the brachytherapy needle guidance device into tissue and a feature at the distal end of the body portion that is capable of penetrating the tissue in order to insert the brachytherapy needle guidance device into the tissue;
imaging the needle guidance device and using a treatment planning software to plan a set of characteristics of insertion of a brachytherapy needle into the treatment region;
inserting the needle guidance device into a treatment region in the tissue; and
anchoring, by the anchoring feature of the needle guidance device, the needle guidance device at the treatment region.
8. The method of claim 7 , wherein providing the needle guidance anchoring feature further comprising providing one of a set of holes for suturing, a set of hooks and an inflatable balloon.
9. The method of claim 7 , wherein providing the needle guidance feature that is capable of penetrating the tissue further comprises providing one of a sharpened tip at a distal end of the hollow body portion and a trocar with an open end.
10. The method of claim 7 , wherein providing the needle guidance body portion further comprises providing one of a guidewire that can be used with a hollow needle and a balloon catheter.
11. The method of claim 7 , wherein imaging the needle guidance device further comprises determining, by an imaging modality, a position and an orientation of needle guidance device in the tissue.
12. A brachytherapy treatment method using needle guidance, the method comprising:
installing a needle guidance device into a treatment region in a tissue;
anchoring the needle guidance device at the treatment region;
determining, by an imaging modality, a position and an orientation of the anchored needle guidance device;
planning, by a treatment planning software based on the position and orientation of the anchored needle guidance device, a set of characteristics for an insertion of a brachytherapy device into the treatment region;
inserting the brachytherapy device using the needle guidance device without imaging into the treatment region during insertion of the brachytherapy device; and
placing, using the brachytherapy device, one or more radioactive seeds into the treatment region.
13. The method of claim 12 further comprising attaching a brachytherapy template onto the needle guidance device and wherein inserting the brachytherapy device further comprises inserting the brachytherapy device through the brachytherapy template into the treatment region.
14. The method of 13, wherein the brachytherapy device further comprises a brachytherapy fiducial needle.
15. The method of claim 12 , wherein installing the needle guidance device further comprises one of penetrating the tissue using a sharpened tip at a distal end of the needle guidance device, using a trocar to install the needle guidance device and inserting a catheter into the tissue using the trocar.
16. The method of claim 13 , wherein anchoring the needle guidance device further comprises one of suturing the needle guidance device once installed into the treatment region and deploying one or more hooks once installed into the treatment region.
17. The method of claim 12 , wherein placing one or more radioactive seeds into the treatment region further comprises placing the one or more radioactive seeds into a lumpectomy cavity in breast tissue.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/991,020 US20230135830A1 (en) | 2019-02-28 | 2022-11-21 | Needle guidance device for brachytherapy and method of use |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962812197P | 2019-02-28 | 2019-02-28 | |
US16/801,103 US11504546B2 (en) | 2019-02-28 | 2020-02-25 | Needle guidance device for brachytherapy and method of use |
US17/991,020 US20230135830A1 (en) | 2019-02-28 | 2022-11-21 | Needle guidance device for brachytherapy and method of use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/801,103 Continuation US11504546B2 (en) | 2019-02-28 | 2020-02-25 | Needle guidance device for brachytherapy and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230135830A1 true US20230135830A1 (en) | 2023-05-04 |
Family
ID=72236622
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/801,103 Active US11504546B2 (en) | 2019-02-28 | 2020-02-25 | Needle guidance device for brachytherapy and method of use |
US17/991,020 Pending US20230135830A1 (en) | 2019-02-28 | 2022-11-21 | Needle guidance device for brachytherapy and method of use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/801,103 Active US11504546B2 (en) | 2019-02-28 | 2020-02-25 | Needle guidance device for brachytherapy and method of use |
Country Status (2)
Country | Link |
---|---|
US (2) | US11504546B2 (en) |
WO (1) | WO2020176677A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
Family Cites Families (126)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3351049A (en) | 1965-04-12 | 1967-11-07 | Hazleton Nuclear Science Corp | Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture |
US3566125A (en) | 1968-07-19 | 1971-02-23 | American Atomics Corp | Radiation excited light source |
US4323055A (en) | 1980-04-08 | 1982-04-06 | Minnesota Mining And Manufacturing Company | Radioactive iodine seed |
US4349033A (en) | 1980-11-06 | 1982-09-14 | Eden Robert D | Intrauterine catheter |
US4763643A (en) | 1981-01-19 | 1988-08-16 | Kinetic Concepts, Inc. | Arc changing apparatus for a therapeutic oscillating bed |
US4509506A (en) | 1981-05-11 | 1985-04-09 | Minnesota Mining & Manufacturing Co. | Shielding device for radioactive seed |
US4401124A (en) | 1981-08-13 | 1983-08-30 | Technicare Corporation | Reflection enhancement of a biopsy needle |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4805628A (en) | 1982-12-06 | 1989-02-21 | Indianapolis Center For Advanced Research, Inc. | Ultrasound contrast media for medically implantable and insertable devices |
US4697575A (en) | 1984-11-21 | 1987-10-06 | Henry Ford Hospital | Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member |
JPS61161446A (en) | 1985-01-10 | 1986-07-22 | Terumo Corp | Ultrasonic wave probe and its production |
US4702228A (en) | 1985-01-24 | 1987-10-27 | Theragenics Corporation | X-ray-emitting interstitial implants |
US4763642A (en) | 1986-04-07 | 1988-08-16 | Horowitz Bruce S | Intracavitational brachytherapy |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US4869259A (en) | 1988-05-17 | 1989-09-26 | Vance Products Incorporated | Echogenically enhanced surgical instrument and method for production thereof |
US4994013A (en) | 1988-07-28 | 1991-02-19 | Best Industries, Inc. | Pellet for a radioactive seed |
US4977897A (en) | 1988-08-17 | 1990-12-18 | Robert Hurwitz | Amniocentesis needle with improved sonographic visibility |
JP2656955B2 (en) | 1988-09-14 | 1997-09-24 | オリンパス光学工業株式会社 | Radiation detection and treatment device |
US4995396A (en) | 1988-12-08 | 1991-02-26 | Olympus Optical Co., Ltd. | Radioactive ray detecting endoscope |
US5289831A (en) | 1989-03-09 | 1994-03-01 | Vance Products Incorporated | Surface-treated stent, catheter, cannula, and the like |
US5081997A (en) | 1989-03-09 | 1992-01-21 | Vance Products Incorporated | Echogenic devices, material and method |
US5201314A (en) | 1989-03-09 | 1993-04-13 | Vance Products Incorporated | Echogenic devices, material and method |
US5698271A (en) | 1989-08-22 | 1997-12-16 | Immunivest Corporation | Methods for the manufacture of magnetically responsive particles |
US6099457A (en) | 1990-08-13 | 2000-08-08 | Endotech, Inc. | Endocurietherapy |
US5342283A (en) | 1990-08-13 | 1994-08-30 | Good Roger R | Endocurietherapy |
US5076278A (en) | 1990-10-15 | 1991-12-31 | Catheter Technology Co. | Annular ultrasonic transducers employing curved surfaces useful in catheter localization |
US5279309A (en) | 1991-06-13 | 1994-01-18 | International Business Machines Corporation | Signaling device and method for monitoring positions in a surgical operation |
US5327891A (en) | 1992-07-30 | 1994-07-12 | Rammler David H | Catheter track and catheter for diagnosis and treatment |
GB9314499D0 (en) | 1993-07-12 | 1993-08-25 | Nycomed Imaging As | Method |
US5490521A (en) | 1993-08-31 | 1996-02-13 | Medtronic, Inc. | Ultrasound biopsy needle |
US6045495A (en) | 1994-01-21 | 2000-04-04 | The Trustees Fo Columbia University In The City Of New York | Apparatus and method to treat a disease process in a luminal structure |
US5460592A (en) | 1994-01-24 | 1995-10-24 | Amersham Holdings, Inc. | Apparatus and method for making carrier assembly for radioactive seed carrier |
US5503614A (en) | 1994-06-08 | 1996-04-02 | Liprie; Samuel F. | Flexible source wire for radiation treatment of diseases |
US5857956A (en) | 1994-06-08 | 1999-01-12 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
US5622687A (en) | 1994-11-15 | 1997-04-22 | Molecular Biosystems, Inc. | Calixarene conjugates useful as MRI and CT diagnostic imaging agents |
FR2731343B1 (en) | 1995-03-08 | 1997-08-22 | De La Joliniere Jean H Bouquet | DEVICE FOR LOCATING SUSPECTED BREAST INJURIES AND APPARATUS FOR PLACING SAME |
EP0889706A1 (en) | 1995-03-08 | 1999-01-13 | TERWILLIGER, Richard, A. | Echogenic needle |
US5766135A (en) | 1995-03-08 | 1998-06-16 | Terwilliger; Richard A. | Echogenic needle tip |
US5611870A (en) | 1995-04-18 | 1997-03-18 | Edtek, Inc. | Filter array for modifying radiant thermal energy |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US5833593A (en) | 1995-11-09 | 1998-11-10 | United States Surgical Corporation | Flexible source wire for localized internal irradiation of tissue |
US6589502B1 (en) | 1995-11-27 | 2003-07-08 | International Brachytherapy S.A. | Radioisotope dispersed in a matrix for brachytherapy |
US5713828A (en) | 1995-11-27 | 1998-02-03 | International Brachytherapy S.A | Hollow-tube brachytherapy device |
EP0778051B1 (en) | 1995-12-05 | 2003-04-09 | Schneider (Europe) GmbH | Filament for irradiating a living body and method for producing a filament for irradiating a living body |
US5617866A (en) | 1996-01-05 | 1997-04-08 | Acuson Corporation | Modular transducer system |
GB9600427D0 (en) | 1996-01-10 | 1996-03-13 | Nycomed Imaging As | Contrast media |
US5821541A (en) | 1996-02-02 | 1998-10-13 | Tuemer; Tuemay O. | Method and apparatus for radiation detection |
NL1003543C2 (en) | 1996-07-08 | 1998-01-12 | Optische Ind Oede Oude Delftoe | Brachytherapy capsule and brachytherapy capsule assembly and guide. |
US5808020A (en) | 1996-08-12 | 1998-09-15 | Associated Universities, Inc. | Optical reaction cell and light source for 18F! fluoride radiotracer synthesis |
US5924973A (en) | 1996-09-26 | 1999-07-20 | The Trustees Of Columbia University In The City Of New York | Method of treating a disease process in a luminal structure |
US6106473A (en) | 1996-11-06 | 2000-08-22 | Sts Biopolymers, Inc. | Echogenic coatings |
US5871437A (en) | 1996-12-10 | 1999-02-16 | Inflow Dynamics, Inc. | Radioactive stent for treating blood vessels to prevent restenosis |
US5759154A (en) | 1996-12-23 | 1998-06-02 | C. R. Bard, Inc. | Print mask technique for echogenic enhancement of a medical device |
US6060040A (en) | 1996-12-23 | 2000-05-09 | Bracco Research S.A. | Cross-linked polymeric compositions for increasing the MRI contrast in visualising the digestive tract of patients |
US5961527A (en) | 1997-01-22 | 1999-10-05 | Barzell Whitmore Maroon Bells, Inc. | Omni-directional precision instrument platform |
US5976067A (en) | 1997-05-28 | 1999-11-02 | Ablation Technologies, Inc. | Combination radioactive and temperature self-regulating thermal seed implant for treating tumors |
US6106454A (en) | 1997-06-17 | 2000-08-22 | Medtronic, Inc. | Medical device for delivering localized radiation |
US6174330B1 (en) | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6010445A (en) | 1997-09-11 | 2000-01-04 | Implant Sciences Corporation | Radioactive medical device and process |
US6030333A (en) | 1997-10-24 | 2000-02-29 | Radiomed Corporation | Implantable radiotherapy device |
US6103295A (en) | 1997-12-22 | 2000-08-15 | Mds Nordion Inc. | Method of affixing radioisotopes onto the surface of a device |
US5961529A (en) | 1998-01-12 | 1999-10-05 | Arnold; James E. | Hourglass-shaped dermal punch and methods for its use |
FR2773887B1 (en) | 1998-01-16 | 2000-03-17 | Smv Int | ADJUSTABLE JOINT FOR TRANSMISSION MITIGATION CORRECTION DEVICE |
US6060036A (en) | 1998-02-09 | 2000-05-09 | Implant Sciences Corporation | Radioactive seed implants |
WO1999040970A1 (en) | 1998-02-12 | 1999-08-19 | Robert Robertson | Encapsulated low-energy brachytherapy sources |
US6095967A (en) | 1998-03-25 | 2000-08-01 | Manan Medical Products, Inc. | Isotope seeding system that releases radioactive seeds for treatment of cancerous cells |
US5997463A (en) | 1998-03-26 | 1999-12-07 | North American Scientific | Laser welded brachytherapy source and method of making the same |
US6086942A (en) | 1998-05-27 | 2000-07-11 | International Brachytherapy S.A. | Fluid-jet deposition of radioactive material for brachytherapy devices |
US6242743B1 (en) | 1998-08-11 | 2001-06-05 | Mosaic Imaging Technology, Inc. | Non-orbiting tomographic imaging system |
US6080099A (en) | 1998-08-12 | 2000-06-27 | Syntheon, Llc | Radioactive therapeutic seeds |
US6007475A (en) | 1998-08-12 | 1999-12-28 | Cns Technology, Inc. | Radioactive therapeutic seeds |
US5921933A (en) | 1998-08-17 | 1999-07-13 | Medtronic, Inc. | Medical devices with echogenic coatings |
US6200255B1 (en) | 1998-10-30 | 2001-03-13 | University Of Rochester | Prostate implant planning engine for radiotherapy |
CN100354980C (en) | 1998-11-06 | 2007-12-12 | 通用电气健康护理有限公司 | Apparatus and method for brachytherapy |
US6066083A (en) | 1998-11-27 | 2000-05-23 | Syntheon Llc | Implantable brachytherapy device having at least partial deactivation capability |
US6132359A (en) | 1999-01-07 | 2000-10-17 | Nycomed Amersham Plc | Brachytherapy seeds |
US6146615A (en) | 1999-01-11 | 2000-11-14 | The University Of Toledo | Contrast agents for image enhancement in magnetic resonance imaging |
US6059714A (en) | 1999-03-26 | 2000-05-09 | Implant Sciences Corporation | Radioactive medical devices |
US6132677A (en) | 1999-04-26 | 2000-10-17 | Lockheed Martin Energy Research Corporation | Method for making radioactive metal articles having small dimensions |
US6221003B1 (en) | 1999-07-26 | 2001-04-24 | Indigo Medical, Incorporated | Brachytherapy cartridge including absorbable and autoclaveable spacer |
US6267718B1 (en) | 1999-07-26 | 2001-07-31 | Ethicon, Endo-Surgery, Inc. | Brachytherapy seed cartridge |
US6364855B1 (en) | 1999-09-01 | 2002-04-02 | Stephen M. Zappala | Multilumen urethral catheter for transperineal brachytherapy |
WO2001028631A1 (en) | 1999-10-15 | 2001-04-26 | Deschutes Medical Products, Inc. | Brachytherapy instrument and methods |
US6398709B1 (en) | 1999-10-19 | 2002-06-04 | Scimed Life Systems, Inc. | Elongated member for intravascular delivery of radiation |
US6579262B1 (en) | 2000-01-25 | 2003-06-17 | Mick Radio-Nuclear Instruments, Inc. | Brachytherapy needle implantation template |
US6564806B1 (en) | 2000-02-18 | 2003-05-20 | Thomas J. Fogarty | Device for accurately marking tissue |
US6361487B1 (en) | 2000-03-09 | 2002-03-26 | Neoseed Technology Llc | Method and apparatus for brachytherapy treatment of prostate disease |
US6621086B1 (en) | 2000-05-11 | 2003-09-16 | Rutgers, The State University Of New Jersey | Radiochromic imaging method |
US6572525B1 (en) | 2000-05-26 | 2003-06-03 | Lisa Yoshizumi | Needle having an aperture for detecting seeds or spacers loaded therein and colored seeds or spacers |
US6846282B1 (en) | 2000-06-09 | 2005-01-25 | Varian Medical Systems, Inc. | Brachytherapy apparatus and methods |
US6949064B2 (en) | 2000-10-20 | 2005-09-27 | Bard Brachytherapy, Inc. | Brachytherapy seed deployment system |
US6508786B2 (en) | 2001-05-22 | 2003-01-21 | Ethicon Endo-Surgery, Inc. | Needle position lock |
US7862495B2 (en) | 2001-05-31 | 2011-01-04 | Advanced Cardiovascular Systems, Inc. | Radiation or drug delivery source with activity gradient to minimize edge effects |
US6549802B2 (en) | 2001-06-07 | 2003-04-15 | Varian Medical Systems, Inc. | Seed localization system and method in ultrasound by fluoroscopy and ultrasound fusion |
US6723052B2 (en) | 2001-06-07 | 2004-04-20 | Stanley L. Mills | Echogenic medical device |
NL1020740C2 (en) * | 2002-06-03 | 2003-12-08 | Nucletron Bv | Method and device for the temporary introduction and placement of at least one energy-emitting source in an animal body. |
EP1374951B1 (en) * | 2002-06-17 | 2010-11-17 | Nucletron B.V. | Template assembly for brachytherapy |
DE60324448D1 (en) | 2002-09-10 | 2008-12-11 | Cianna Medical Inc | brachytherapy |
US7815561B2 (en) | 2003-09-25 | 2010-10-19 | Xoft, Inc. | Brachytherapy applicator |
WO2005092197A1 (en) * | 2004-03-09 | 2005-10-06 | Robarts Research Institute | An apparatus and computing device for performing brachytherapy and methods of imaging using the same |
US7662082B2 (en) | 2004-11-05 | 2010-02-16 | Theragenics Corporation | Expandable brachytherapy device |
NL1027562C2 (en) | 2004-11-23 | 2006-05-24 | Isodose Control Intellectual P | Catheter needle. |
GB0504988D0 (en) | 2005-03-10 | 2005-04-20 | Emcision Ltd | Device and method for the treatment of diseased tissue such as tumors |
US7527593B2 (en) | 2005-06-11 | 2009-05-05 | Fidel Howard F | Active template guide plate and system and method for utilizing same |
CA2613286A1 (en) | 2005-06-21 | 2007-01-04 | Naviscan Pet Systems, Inc. | Tissue interventions using nuclear-emission image guidance |
US7736293B2 (en) | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
BRPI0616514A2 (en) | 2005-08-11 | 2011-06-21 | Navotek Medical Ltd | medical treatment system and method using position sensor based radioactivity |
US20070049786A1 (en) | 2005-08-30 | 2007-03-01 | Cytyc Corporation | Safety-link brachytherapy catheter |
WO2007064937A1 (en) | 2005-12-02 | 2007-06-07 | University Of Rochester | Image-guided therapy delivery and diagnostic needle system |
US20070270627A1 (en) | 2005-12-16 | 2007-11-22 | North American Scientific | Brachytherapy apparatus for asymmetrical body cavities |
US20070265487A1 (en) | 2006-05-09 | 2007-11-15 | Worldwide Medical Technologies Llc | Applicators for use in positioning implants for use in brachytherapy and other radiation therapy |
NL1031786C1 (en) | 2006-05-10 | 2007-11-13 | Isodose Control Intellectual P | Catheter needle for internal irradiation of a tumor in a body part. |
US8734313B2 (en) | 2006-10-04 | 2014-05-27 | Hampton University | Accelerated partial breast irradiation with shielded brachytherapy applicator system and method of use |
US8764619B2 (en) | 2009-04-21 | 2014-07-01 | Breast Microseed Llc | Brachytherapy fiducial needle fixation system and method |
US9014787B2 (en) | 2009-06-01 | 2015-04-21 | Focal Therapeutics, Inc. | Bioabsorbable target for diagnostic or therapeutic procedure |
CA2824521C (en) | 2011-01-20 | 2016-06-28 | Board Of Regents, The University Of Texas System | Mri markers, delivery and extraction systems, and related methods |
US20130289389A1 (en) | 2012-04-26 | 2013-10-31 | Focal Therapeutics | Surgical implant for marking soft tissue |
US20170296842A1 (en) | 2012-08-27 | 2017-10-19 | Medi-Physics, Inc. | Brachytherapy template adaptor |
US10286114B2 (en) | 2013-03-13 | 2019-05-14 | Focal Therapeutics, Inc. | Device and method for targeted radiation therapy |
US10335609B2 (en) | 2013-03-12 | 2019-07-02 | The Cleveland Clinic Foundation | Multitube esophageal brachytherapy catheter |
CA2955956C (en) | 2014-07-25 | 2022-10-18 | Focal Therapeutics, Inc. | Implantable devices and techniques for oncoplastic surgery |
US10293178B2 (en) * | 2014-12-10 | 2019-05-21 | Nucletron Operations B.V. | Brachytherapy position verification system and methods of use |
KR101752973B1 (en) | 2015-09-25 | 2017-07-03 | 경희대학교 산학협력단 | Phantom apparatus for measuring dose of remote radiation |
US10398526B2 (en) | 2015-11-30 | 2019-09-03 | Trod Medical | Assembly for positioning electrodes for radiofrequency tissue ablation |
US20200276455A1 (en) | 2019-02-28 | 2020-09-03 | Breast Microseed, Inc. | Apparatus for precise positioning of brachytherapy template |
US11524176B2 (en) | 2019-03-14 | 2022-12-13 | Cowles Ventures, Llc | Locator for placement of fiducial support device method |
-
2020
- 2020-02-25 US US16/801,103 patent/US11504546B2/en active Active
- 2020-02-26 WO PCT/US2020/019985 patent/WO2020176677A1/en active Application Filing
-
2022
- 2022-11-21 US US17/991,020 patent/US20230135830A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2020176677A1 (en) | 2020-09-03 |
US20200276451A1 (en) | 2020-09-03 |
US11504546B2 (en) | 2022-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11944509B2 (en) | Surgical implant for marking soft tissue | |
US20230173302A1 (en) | Locator for placement of fiducial support device method | |
US10456592B2 (en) | Brachytherapy fiducial needle fixation system | |
US8170647B2 (en) | Fiduciary markers and method of use thereof | |
US9492683B2 (en) | Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors | |
US20230135830A1 (en) | Needle guidance device for brachytherapy and method of use | |
JP6930830B2 (en) | Brachytherapy clips and applicators | |
US20200276455A1 (en) | Apparatus for precise positioning of brachytherapy template | |
Jansen et al. | Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation | |
Merrick et al. | American brachytherapy society prostate low-dose rate task group | |
US20240100356A1 (en) | Customized brachytherapy needle template and method | |
CA3221691A1 (en) | Automated brachytherapy with robotics and/or image guidance | |
Gruszczynska et al. | Image-guided high-dose-rate brachytherapy for prostate cancer patients with previous rectal resection and pelvic irradiation: feasibility study | |
Jiang et al. | Software tool for breast cancer brachytherapy planning using VTK | |
Hoskin et al. | Breast brachytherapy | |
Dicker et al. | Salvage of suboptimal prostate seed implantation: re-implantation of an underdosed region of the prostate base | |
Yankelevich et al. | On Board Imager based MammoSite treatment verification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: COWLES VENTURES, LLC, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CONCURE ONCOLOGY, INC.;REEL/FRAME:061839/0791 Effective date: 20211220 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |